Commentary: Reconsidering Pharmaceutical Research and Development Investments
Sign Up to like & getrecommendations! Published in 2023 at "Healthcare Policy"
DOI: 10.12927/hcpol.2023.27037
Abstract: Following Lee and colleagues' (2023) article explaining how Canadians are being shortchanged by drug companies when it comes to investments in research and development (R&D), this rejoinder adds context and appends two other very problematic… read more here.
Keywords: reconsidering pharmaceutical; research development; commentary reconsidering; pharmaceutical research ... See more keywords